<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01058603</url>
  </required_header>
  <id_info>
    <org_study_id>07F/END01</org_study_id>
    <nct_id>NCT01058603</nct_id>
  </id_info>
  <brief_title>Efficacy of Endocell® vs Conventional Medium in the Treatment of Infertility</brief_title>
  <official_title>Multicentre, Randomised, Controlled Clinical Study on the Efficacy in Terms of Clinical Pregnancy Rate of 1 Embryo Transfer at Day 5 After Co-culture on Autologous Endometrial Cells(ENDOCELL®) Versus 1 Embryo Transfer at Day 3 After Culture on Conventional Medium.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Genévrier</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Genévrier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to demonstrate the efficacy of a single embryo transfer at
      blastocyst stage (Day 5) after co-culture on Autologous Endometrial Cell Culture (AECC)
      versus transfer of a single embryo at Day 3 after culture in conventional medium. Efficacy
      will be assessed in terms of clinical pregnancy rate 5 to 8 weeks after embryo transfer.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>- Conventional culture medium for IVF</intervention_name>
    <description>Embryos are cultured on conventional medium and transferred at Day 3. Supernumerary good quality embryos are frozen</description>
    <arm_group_label>D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>- Endocell®</intervention_name>
    <description>Embryos are cultured on ENDOCELL® from Day 2 to Day 5 (Blastocyst stage) One embryo is transferred at Day 5. Supernumerary good quality embryos are frozen.</description>
    <arm_group_label>D5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged ≥ 18 and ≤ 36

          -  Undergoing ovarian stimulation for an In Vitro Fertilization (IVF) or Intra
             Cytoplasmic Sperm Injection (ICSI)

          -  Having experienced no more than 1 Embryo Transfer failure

          -  With basal FSH level ≤ 12 IU/l within the 6 months prior to the study

          -  Endometrial biopsy during the menstrual cycle preceding the ovarian stimulation (6 to
             12 days after a documented ovulation)

          -  Negative serology for HIV 1 and 2, hepatitis B and C, HTLV 1 and 2, syphilis

        Exclusion Criteria:

          -  Hypersensitivity to one of the culture media components

          -  Oocyte donation, sperm donation

          -  Thawed embryos transfer

          -  Women with endometriosis grade III and IV, chronic endometritis, hydrosalpinx,
             polycystic ovary, amenorrhoea, anovulation, uterus with malformation, uncontrolled
             prolactinaemia, uterine synechia, uterine fibroma, women exposed to distilbene,
             uterine polyps

          -  Women affected by pathologies associated with any contraindication of being pregnant

          -  Abnormal gynaecologic bleeding of undetermined origin

          -  Uncontrolled thyroid (TSH dosage) or adrenal dysfunction

          -  Neoplasias, any pathologies of the endometrium or the cervix
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anissa Benoussaidh</last_name>
    <phone>+33-492914134</phone>
    <email>abenoussaidh@laboratoires-genevrier.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CMCO</name>
      <address>
        <city>Schiltigheim</city>
        <zip>67303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanine Ohl, MD</last_name>
      <phone>00 (33)3.88.62.84.34</phone>
      <email>Jeanin.OHL@sihcus.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2010</study_first_submitted>
  <study_first_submitted_qc>January 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2010</study_first_posted>
  <last_update_submitted>February 3, 2010</last_update_submitted>
  <last_update_submitted_qc>February 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2010</last_update_posted>
  <responsible_party>
    <organization>Laboratoires Genévrier</organization>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Cell Culture</keyword>
  <keyword>AECC</keyword>
  <keyword>Endocell</keyword>
  <keyword>IVF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

